Chas Pulido is a 3rd generation healthcare CEO, serial entrepreneur, & venture capitalist with a passion for helping startups drive patient impact.
Chas founded Alix Ventures, where he serves as General Partner, to support high potential early stage Life Science startups engineering biology to drive radical advances in human health. He is particularly excited about startups at the intersection of technology & biology, known as “TechBio”, building platforms for “Novel Applications” (Therapeutics/Diagnostics) & “Bio-Economy Infrastructure” (Services/Manufacturing).
Recognizing the TechBio movement at hand, Chas created BIOS – Content & community platform to unite Life Science industry innovators. To learn more about BIOS & initiatives check out: BIOS Medium (Top Writer – Venture Capital), BIOS Podcast (Top 100 Life Sciences), BIOS Daily Newsletter (25K+ Subscribers), BIOS Angels (World’s First TechBio Angel Investing Syndicate), & join our community – BIOS Commons (1000+ Members).
Chas began his entrepreneurial pursuits at The University of Notre Dame where he majored in Management Consulting and served as an Innovation Fellow. His interests took him west to Silicon Valley through Y-Combinator with the founding of Pareto Life Sciences, the world’s first stem cell marketplace. In an effort to help patients access breakthrough treatments, he joined Clara Health (Acquired by M&B Sciences) – a leading clinical trial innovation startup – as an early employee to head business development & operations.